This article is available online at http://www.jlr.org Cardiovascular disease (CVD) has a complex etiology and is the leading cause of death in the United States ( 1 ). Risk factors for CVD include dyslipidemia (e.g., high plasma cholesterol and triglycerides), elevated blood pressure (e.g., hypertension), and obesity [e.g., body mass index (BMI) > 30.0 kg/m 2 ]. These factors have strong environmental contributions, including whether an individual smokes, activity level, and percentage of dietary saturated fat ( 2 ). Heritability estimates for the risk factors of CVD indicate there is a strong genetic contribution as well, and heritabilities vary between the sexes as well as within and across ethnic populations ( 3 ). Many candidate genes for CVD risk factors have been identifi ed in human linkage and in genome-wide association studies (GWAS) ( 4 ). However, these genes account for a very small proportion of the overall heritable variation of risk, approximately 5-10% cumulatively ( 5 ). This is due partly to the confounding factors of genetic and environmental heterogeneity in human populations and partly to the lack of statistical power to detect genes with small phenotypic effects, those genes that underlie much of the variation in complex traits, such as circulating lipid levels, blood pressure, and obesity.Despite not developing CVD per se, mice have nevertheless made major contributions to our knowledge of disease etiology, particularly in our understanding of disease physiology and in our identifi cation of genetic risk factors. This is because phenotypes are ascertained in controlled environments and large numbers of offspring are generated